Clinical Trial Update: Oral Azacitidine Combined With Venetoclax in Previously Untreated Higher-risk Myelodysplastic Syndromes [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial is evaluating oral azacitidine combined with venetoclax in previously untreated higher-risk myelodysplastic syndromes; the study is c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myelodysplastic Syndromes

Drugs mentioned

• Oral azacitidine (azacitidine (oral formulation))
• Venetoclax (venetoclax)

Snippet

Sponsor: Groupe Francophone des Myelodysplasies | Conditions: Untreated Myelodysplastic Syndrome | Phase 1, Phase 2 | Status: ACTIVE_NOT_RECRUITING